AU8096998A - Attenuated human immunodeficiency virus vaccine - Google Patents

Attenuated human immunodeficiency virus vaccine

Info

Publication number
AU8096998A
AU8096998A AU80969/98A AU8096998A AU8096998A AU 8096998 A AU8096998 A AU 8096998A AU 80969/98 A AU80969/98 A AU 80969/98A AU 8096998 A AU8096998 A AU 8096998A AU 8096998 A AU8096998 A AU 8096998A
Authority
AU
Australia
Prior art keywords
immunodeficiency virus
human immunodeficiency
virus vaccine
attenuated human
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80969/98A
Inventor
Mark A. Wainberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sir Mortimer B Davis Jewish General Hospita
Original Assignee
Sir Mortimer B Davis Jewish General Hospita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sir Mortimer B Davis Jewish General Hospita filed Critical Sir Mortimer B Davis Jewish General Hospita
Publication of AU8096998A publication Critical patent/AU8096998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU80969/98A 1997-06-26 1998-06-26 Attenuated human immunodeficiency virus vaccine Abandoned AU8096998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002208946A CA2208946A1 (en) 1997-06-26 1997-06-26 Attenuated human immunodeficiency virus vaccine
CA2208946 1997-06-26
PCT/CA1998/000617 WO1999000490A2 (en) 1997-06-26 1998-06-26 Attenuated human immunodeficiency virus vaccine

Publications (1)

Publication Number Publication Date
AU8096998A true AU8096998A (en) 1999-01-19

Family

ID=4160956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80969/98A Abandoned AU8096998A (en) 1997-06-26 1998-06-26 Attenuated human immunodeficiency virus vaccine

Country Status (3)

Country Link
AU (1) AU8096998A (en)
CA (1) CA2208946A1 (en)
WO (1) WO1999000490A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012535A2 (en) * 2003-08-01 2005-02-10 Phytovation B.V. Method for producing life attenuated viruses and use of viral particles thus produced.
CA2785924A1 (en) 2010-01-04 2011-07-07 Novozymes A/S Alpha-amylases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580761A (en) * 1988-02-16 1996-12-03 Greatbatch Gen-Aid Ltd. Method of conferring resistance to immunodeficiency viral infection

Also Published As

Publication number Publication date
CA2208946A1 (en) 1998-12-26
WO1999000490A2 (en) 1999-01-07
WO1999000490A3 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
AU5726694A (en) Human immunodeficiency virus decoy
GB2337755B (en) Virus vaccine
AU6065998A (en) Influenza vaccine
AU1308495A (en) Influenza vaccine
AU4878096A (en) Hepatitis b vaccine
IL150961A0 (en) Human immunodeficiency virus vaccine
AU1508699A (en) Live attenuated influenza vaccine
ZA924150B (en) Vaccine for human immunodeficiency virus
AU1285300A (en) Hiv vaccine
AU3125795A (en) Attenuated human rotavirus vaccine
AU9186598A (en) Killer t cell receptor recognizing human immunodeficiency virus
GB9420146D0 (en) Papillomavirus vaccine
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
EP0967993A4 (en) Anti-cocaine vaccine
AU6445798A (en) Feline immunodeficiency virus clone jsy3
AU4450696A (en) Enhanced immunogenic vaccine
AU3552797A (en) Vaccine preparations
AU1194997A (en) Plasmid vaccine against pseudorabies virus
AU8096998A (en) Attenuated human immunodeficiency virus vaccine
AU2960000A (en) Detection of human immunodeficiency virus
AU4957800A (en) Vaccine against isa virus
AU6736998A (en) Fiv vaccine
GB9702990D0 (en) Virus vaccine
AU7336296A (en) Human hepatitis b virus dna

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase